Pregled bibliografske jedinice broj: 443875
Cardiovascular drugs utilization in Croatia during a four-year period
Cardiovascular drugs utilization in Croatia during a four-year period // Abstracts of the 15th World Congress of Pharmacology ; u: Acta Pharmacologica Sinica 27 (2006) (S1)
Peking: Wiley-Blackwell, 2006. str. P204-P204 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 443875 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cardiovascular drugs utilization in Croatia during a four-year period
Autori
Vitezić, Dinko ; Matana, Zrinka ; Buble, Tonči ; Mršić-Pelčić, Jasenka ; Knežević, Aleksandar ; Bagatin, Jugoslav ; Župan, Gordana ; Simonić, Ante
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 15th World Congress of Pharmacology ; u: Acta Pharmacologica Sinica 27 (2006) (S1)
/ - Peking : Wiley-Blackwell, 2006, P204-P204
Skup
World Congress of Pharmacology (15 ; 2006)
Mjesto i datum
Peking, Kina, 02.07.2006. - 07.07.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
cardiovascular drugs; drug utilization; health insurance
Sažetak
The aim of this work was to identify and present changes in the utilization of CV drugs in Croatia during the period 2000-2004 and discuss the underlying reasons. Information data on CV drugs utilization fix the period 2001-2004 were obtained from the Croatian National Health Insurance. Drug utilization data are presented in defined daily doses/1000 inhabitants/day (DDD/1000). Comparing 2004 vs. 2001, total CV drugs utilization increased 49.53% from 176.80 to 264.37 DDD/1000. The statins had the highest share rise from 5.88% to 10.90%. Drugs acting on the renin-angiotensin system had the largest share (32%). The utilization of angiotensin II antagonists and the combination of ACE inhibitors and diuretics increased from 1.12 to 6.96 and from 10.07 to 26.85 DDD/1000, respectively. The utilization of the new calcium channel blockers (CCB) increased 1.27 times and the old CCB decreased 18%. The utilization of most CV drugs in Croatia increased during this relatively short study period and we presume that the main reason is a legal change (the new Insurance Act) with the introduction of supplementary health insurance.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0062049
Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Split,
Opća bolnica Zadar
Profili:
Jugoslav Bagatin
(autor)
Dinko Vitezić
(autor)
Jasenka Mršić-Pelčić
(autor)
Aleksandar Knežević
(autor)
Ante Simonić
(autor)
Gordana Župan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE